Progyny (PGNY)
NASDAQ:PGNY
Earnings Data
Report Date
May 07, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.26Last Year’s EPS
0.17Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed materially positive operational and financial momentum: record revenue, adjusted EBITDA and operating cash flow; margin expansion and healthy member engagement; strong balance sheet and active share repurchases. The company is investing in product expansion (Progyny Select, Rx and maternal health services) while managing risk via conservative guidance assumptions. Key near-term negatives include an administrative reduction in reported covered lives (~400k), a one-time $7.7 million stock-comp acceleration, elevated CapEx in 2025, and guidance conservatism to account for utilization variability and regulatory uncertainty in pharmacy rebates. Overall, the positives (record results, cash generation, margin gains, client retention and product runway) outweigh the transitory and manageable lowlights.Company Guidance
Record Revenue and Adjusted EBITDA
Full-year 2025 revenue of $1.29 billion and adjusted EBITDA of $222 million, both up double digits versus 2024; results were nearly $90 million (revenue) and $28 million (adjusted EBITDA) above the midpoint of original 2025 guidance.
Strong Operating Cash Flow and Balance Sheet
Record operating cash flow of $210 million in 2025, an increase of ~17% year-over-year (Mark cited a $31 million increase); total working capital approx. $350 million including $310 million in cash and marketable securities; no debt and no borrowings on $200 million revolver.
Revenue Growth Trends (Reported and Adjusted)
Q4 revenue growth was 7% as-reported (or 21% excluding a large former client). Full-year revenue grew 10% as-reported (or 20% excluding the transition client). 2026 revenue guidance of $1.355B–$1.405B implies +5.1% to +9% growth (or +9.3% to +13.3% excluding the transition client).
Gross Margin and Profitability Expansion
Nearly 200 basis points expansion in full-year gross margin versus 2024, reflecting care-management and scale efficiencies. Adjusted EBITDA margins modestly improved in both Q4 and FY 2025 despite continued investments.
High Client Retention, Upsells and Member Access Expansion
Near 100% client retention including all largest employers; 30% of the client base expanded benefits for 2026 via upsells and service enhancements; over 2.7 million members will have access to new pregnancy, postpartum and menopause services in 2026.
Capital Allocation — Share Repurchases
Repurchased >3.3 million shares (~$84 million) during the quarter and ~6.5 million shares total to date, with >$40 million remaining under a $200 million authorization.
Product and Market Expansion Initiatives
Announced Progyny Select targeting the 50 million fully insured lives market (pricing designed with guardrails); Progyny Rx continues to include point-of-sale rebates and management sees no employer pushback to date. Select is expected to contribute financially starting in 2027.
PGNY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PGNY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 26, 2026 | $22.25 | $17.69 | -20.49% |
Nov 06, 2025 | $18.01 | $22.37 | +24.21% |
Aug 07, 2025 | $23.06 | $22.85 | -0.91% |
May 08, 2025 | $23.37 | $21.19 | -9.33% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Progyny (PGNY) report earnings?
Progyny (PGNY) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
What is Progyny (PGNY) earnings time?
Progyny (PGNY) earnings time is at May 07, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PGNY EPS forecast?
PGNY EPS forecast for the fiscal quarter 2026 (Q1) is 0.26.